Invasive Imaging of Bioresorbable Coronary Scaffolds - A Review

Overview

Journal Interv Cardiol

Date 2018 Mar 29

PMID 29588747

Authors

Nienke S van Ditzhuijzen

Jurgen Mr Ligthart

Nico Bruining

Evelyn Regar

Heleen Mm van Beusekom

Affiliations

Soon will be listed here.

Abstract

Various fully bioresorbable stents (BRS) have been recently developed, allowing for temporary scaffolding of the vessel wall. The potentially unique advantage of BRS to temporary scaffold the vessel could reduce the risk of adverse clinical outcomes caused by acute vessel geometry changes, late malapposition, jailed side branches or inflexibility of permanent stents. The design of BRS is, however, not similar for all stents, resulting in differences in degradation and behaviour. To assess the performance of BRS, the effect of degradation and behaviour on the vessel wall should be accurately evaluated. Intracoronary imaging techniques such as intravascular ultrasound (IVUS), optical coherence tomography (OCT) and near-infrared spectroscopy (NIRS) allow for detailed longitudinal evaluation of the stent and the vessel wall and might therefore aid in improving design and behaviour of BRS.

References

Nair A, Kuban B, Tuzcu E, Schoenhagen P, Nissen S, Geoffrey Vince D . Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002; 106(17):2200-6. DOI: 10.1161/01.cir.0000035654.18341.5e. View

Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T . Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation. 2012; 125(19):2343-53. DOI: 10.1161/CIRCULATIONAHA.110.000901. View

Onuma Y, Garg S, Okamura T, Ligthart J, van Geuns R, de Feyter P . Ten-year follow-up of the IGAKI-TAMAI stent. A posthumous tribute to the scientific work of Dr. Hideo Tamai. EuroIntervention. 2011; 5 Suppl F:F109-11. DOI: 10.4244/EIJV5IFA19. View

Tu S, Xu L, Ligthart J, Xu B, Witberg K, Sun Z . In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int J Cardiovasc Imaging. 2012; 28(6):1315-27. PMC: 3463784. DOI: 10.1007/s10554-012-0016-6. View

Mintz G, Nissen S, Anderson W, Bailey S, Erbel R, Fitzgerald P . American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert.... J Am Coll Cardiol. 2001; 37(5):1478-92. DOI: 10.1016/s0735-1097(01)01175-5. View

Gardner C, Tan H, Hull E, Lisauskas J, Sum S, Meese T . Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging. 2009; 1(5):638-48. DOI: 10.1016/j.jcmg.2008.06.001. View

Okamura T, Garg S, Gutierrez-Chico J, Shin E, Onuma Y, Garcia-Garcia H . In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. EuroIntervention. 2010; 5(8):932-8. View

Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S . Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation. 2000; 102(4):399-404. DOI: 10.1161/01.cir.102.4.399. View

Haude M, Erbel R, Erne P, Verheye S, Degen H, Bose D . Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet. 2013; 381(9869):836-44. DOI: 10.1016/S0140-6736(12)61765-6. View

10.

Serruys P, Garcia-Garcia H, Onuma Y . From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?. Eur Heart J. 2011; 33(1):16-25b. DOI: 10.1093/eurheartj/ehr384. View

11.

Serruys P, Ormiston J, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia H . A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009; 373(9667):897-910. DOI: 10.1016/S0140-6736(09)60325-1. View

12.

Gruntzig A, SENNING A, SIEGENTHALER W . Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979; 301(2):61-8. DOI: 10.1056/NEJM197907123010201. View

13.

Garg S, Serruys P, van der Ent M, Schultz C, Mastik F, van Soest G . First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque. EuroIntervention. 2010; 5(6):755-6. DOI: 10.4244/eijv5i6a126. View

14.

Madder R, Steinberg D, Anderson R . Multimodality direct coronary imaging with combined near-infrared spectroscopy and intravascular ultrasound: initial US experience. Catheter Cardiovasc Interv. 2011; 81(3):551-7. DOI: 10.1002/ccd.23358. View

15.

Schultz C, Serruys P, van der Ent M, Ligthart J, Mastik F, Garg S . First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow?. J Am Coll Cardiol. 2010; 56(4):314. DOI: 10.1016/j.jacc.2009.10.090. View

16.

van Ditzhuijzen N, van den Heuvel M, Sorop O, van Duin R, Krabbendam-Peters I, van Haeren R . Invasive coronary imaging in animal models of atherosclerosis. Neth Heart J. 2011; 19(10):442-6. PMC: 3189316. DOI: 10.1007/s12471-011-0187-0. View

17.

Brugaletta S, Garcia-Garcia H, Garg S, Gomez-Lara J, Diletti R, Onuma Y . Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging. 2010; 27(6):859-66. DOI: 10.1007/s10554-010-9724-y. View

18.

Tu S, Holm N, Koning G, Huang Z, Reiber J . Fusion of 3D QCA and IVUS/OCT. Int J Cardiovasc Imaging. 2011; 27(2):197-207. PMC: 3078305. DOI: 10.1007/s10554-011-9809-2. View

19.

Erbel R, Di Mario C, Bartunek J, Bonnier J, De Bruyne B, Eberli F . Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007; 369(9576):1869-1875. DOI: 10.1016/S0140-6736(07)60853-8. View

20.

Bruining N, de Winter S, Roelandt J, Regar E, Heller I, van Domburg R . Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. JACC Cardiovasc Interv. 2010; 3(4):449-56. DOI: 10.1016/j.jcin.2010.02.004. View